Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award | Pharmaceutical | Abdul Wali Khan University Mardan | Pakistan

Dr. Muhammad Bilal Afridi is a dedicated pharmaceutical scientist and clinical pharmacist recognized for his expertise in drug synthesis, pharmacological modeling, and computational chemistry. With a profound academic background and more than a decade of professional experience, Dr. Afridi has established himself as a leading researcher in the domain of synthetic and therapeutic drug development. He earned his Ph.D. in Pharmaceutical Sciences from Abdul Wali Khan University, Mardan, where his doctoral research focused on the synthesis, characterization, computational studies, and pharmacological potential of synthetic curcumin derivatives aimed at addressing diabetes and amnesia-related disorders. His earlier academic milestones include an M.Phil in Pharmaceutical Sciences from Abdul Wali Khan University and a Doctor of Pharmacy (Pharm-D) from Kohat University of Science and Technology. Professionally, Dr. Muhammad Bilal Afridi has served as a pharmacist at the Institute of Kidney Diseases (IKD), Peshawar, where he managed hospital pharmacy operations, clinical pharmacy services, and patient safety programs. His leadership extended to training junior pharmacists, supervising pharmacy interns, and participating in institutional Drug and Therapeutic Committees. His previous tenures at Rehman Medical Institute and D. Watson Chemist allowed him to develop robust skills in patient counseling, prescription review, pharmacovigilance, and rational drug use. Dr. Afridi’s research interests encompass computational drug design, molecular docking, pharmacodynamics, and synthesis of bioactive compounds, reflecting his interdisciplinary approach that bridges chemistry, pharmacology, and computational biology. His published works in highly regarded journals, including Computational Biology and Chemistry, Inorganic Chemistry Communications, and Current Molecular Pharmacology, contribute significantly to advancing medicinal chemistry and pharmaceutical innovation. He has demonstrated strong analytical and technical skills in density functional theory (DFT) modeling, ADMET prediction, and spectral analysis. Dr. Muhammad Bilal Afridi’s professional competencies include teaching, mentoring, research supervision, and scientific writing, backed by proficiency in tools like EndNote and MS Office. His contributions have been acknowledged through multiple peer-reviewed publications, collaborations with international researchers from Türkiye and Saudi Arabia, and recognition in academic circles for his commitment to scientific excellence. He continues to serve as a role model for young researchers in Pakistan through his dedication to patient-centered research and academic mentorship. His unwavering commitment to bridging pharmaceutical sciences and clinical applications makes him a strong candidate for recognition in global research excellence. Dr. Muhammad Bilal Afridi stands as an emerging leader with a promising future in international pharmaceutical research, committed to innovation, integrity, and impactful contributions to human health and medicine.

Profile: Scopus

Featured Publications 

  1. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). SwissADME studies and density functional theory (DFT) approaches of methyl substituted curcumin derivatives. Computational Biology and Chemistry, 112, 108153. (Cited by 8)

  2. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). In silico ADMET and DFT analysis of methoxy substituted curcumin derivatives. Inorganic Chemistry Communications, 168, 112943. (Cited by 6)

  3. Afridi, M. B., Khan, H., Ali Shah, S. W., Zafar, M., Almalki, A. S., Ghias, M., & Rahman, N. (2022). In-vivo anti-nociceptive activities of Schiff bases aldehyde derivatives of 4-aminoantipyrine and their molecular docking studies. Main Group Chemistry, 21(2), 373–386. (Cited by 10)

  4. Afridi, M. B., Khan, H., Akkol, E. K., & Aschner, M. (2021). Pain perception and management: Where do we stand? Current Molecular Pharmacology, 14(5), 678–688. (Cited by 25)

  5. Afridi, M. B., Sardar, H., Shah, S. W. A., Serdaroğlu, G., & Khan, H. (2025). Exploring anticholinergic and anti-amnesic potential of methyl substituted monocarbonyl curcumin derivatives. European Journal of Pharmacology, 950, 182653. (Cited by 2)

  6. Afridi, M. B., Khan, H., & Shah, S. W. A. (2023). Computational evaluation of synthetic curcumin analogs for neuroprotective potential using molecular docking approaches. Journal of Molecular Structure, 1287, 135623. (Cited by 4)

  7. Afridi, M. B., Sardar, H., & Khan, H. (2023). Pharmacological insights into curcumin derivatives: A computational and experimental perspective. Bioorganic Chemistry, 137, 106707. (Cited by 3)

 

Tianhui Yuan | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Dr. Tianhui Yuan | Medicine and Health Sciences | Best Researcher Award

Associate Director | The First Affiliated Hospital of Guangzhou University of Medicine | China

Prof. Dr. Tianhui Yuan is a distinguished physician-scientist whose educational journey culminated in the M.D. and a Ph.D. in integrated medicine and cardiovascular science (with doctoral training at a leading university), and she currently serves as Chief Physician, Doctoral Supervisor, and Associate Director of her department while also holding a Visiting Scholar appointment in the United States. Over her career, she has held progressive roles in clinical practice, laboratory research, and academic leadership in integrative Chinese and Western medicine. Her professional experience spans directing clinical care units in cardiovascular medicine, mentoring doctoral and postdoctoral researchers, coordinating international research collaborations, and representing her institution in health policy and traditional medicine networks. Her research interests lie at the interface between traditional Chinese medicine and modern cardiovascular disease therapy, particularly focusing on mechanisms and therapeutic strategies for heart failure, cardiomyopathy, coronary artery disease, hypertension, arrhythmia, hyperlipidemia, and insomnia. She is skilled in experimental cardiovascular physiology, molecular biology, signaling pathway analysis, preclinical animal models, translational interventions, and clinical guideline development. She has made significant scholarly contributions: she has authored 15 documents, received 154 Citations, and holds an h-index of 7, reflecting a growing impact. Among her honors and awards, she has been selected for the Guangdong Provincial Health Commission’s “Guangdong Special Support Program” and the “Youth Talent Support Program,” and she holds recognition as a young academic leader at her university; she also serves on multiple national and international professional committees and has contributed to guideline development, patent filing (2 invention patents), software intellectual property (1 software copyright), and the authorship of 9 books. Through mentorship she has guided student teams to high distinction in innovation competitions and has been invited as a keynote speaker at major conferences like the ESC Heart Failure Congress and the International Heart Congress. Given her solid educational foundation, extensive clinical and research experience, integrative medicine focus, leadership roles, and peer-recognized contributions, Prof. Dr. Tianhui Yuan is exceptionally well positioned to advance her field further, strengthen international collaborations, expand high-impact publication outputs, and mentor the next generation of integrative cardiovascular researchers.

Profile: Scopus

Featured Publications

  1. Ma, X., … Yuan, T. (2023). Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula to prevent myocardial ischemia. Journal Name.

  2. Dong, X., Han, X., Zhang, X., … Yuan, T. (2022). A simplified herbal formula improves cardiac function and reduces inflammation in mice through the TLR-mediated NF-κB signaling pathway. Journal Name.

  3. Yang, Z., Xian, S., Yuan, T. (2020). Dexmedetomidine-mediated regulation of miR-17-3p in H9C2 cells after hypoxia/reoxygenation injury. Journal Name.

  4. Yuan, T., Chen, Y., Zhou, X., … (2019). Effectiveness and safety of Danshen injection on heart failure: protocol for a systematic review and meta-analysis. Journal Name.

  5. Wang, L., Gao, M., Chen, J., … (2015). Resveratrol ameliorates pressure overload-induced cardiac dysfunction and attenuates autophagy in rats. Journal Name.

 

Esmaeil Mehraeen | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Esmaeil Mehraeen | Medicine and Health Sciences | Best Researcher Award

Dr Esmaeil Mehraeen, Khalkhal University of Medical Sciences, Iran

Dr. Esmaeil Mehraeen is an esteemed health informatics expert recognized for his contributions to medical research, particularly in health information management and digital health solutions. His research spans HIV self-management, telemedicine, AI in healthcare, and pandemic response strategies. A prolific author, he has published extensively on innovative healthcare technologies, ethical AI applications, and epidemiological assessments. His dedication to advancing medical informatics earned him recognition as the top researcher in Ardabil province in 2021. With a strong academic and executive background, he continues to shape the future of health informatics, making him an ideal candidate for the Best Researcher Award.

Publication Profile

Google Scholar

Education

Dr. Esmaeil Mehraeen is a dedicated expert in Health Information Management 📊🩺, earning his Ph.D. from Tehran University of Medical Sciences (2015-2018). His doctoral research focused on designing, developing, and evaluating a mobile and web-based intelligent self-management system for people living with HIV 📱💡. He previously completed an MSc in Medical Records Education (2010-2012) at the same university, where he explored information security in hospital information systems at Tehran and Shahid Beheshti Universities 🏥🔐. His academic journey began with a BSc in Medical Records (2005-2007) from Shahid Beheshti University of Medical Sciences 📑📚, laying the foundation for his expertise in health data management and security. With a strong background in digital health solutions and medical informatics, Dr. Mehraeen contributes to improving healthcare technology and patient self-management systems 🏥📲. His work bridges the gap between healthcare and innovative digital tools, ensuring secure and efficient health information management 🔍💻.

Experience

Dr. Esmaeil Mehraeen is a dedicated academic and researcher in medical sciences 🏥📚. He has served as a Faculty Member at Khalkhal University of Medical Sciences (2018-2024) 👨‍🏫 and previously held the same role at Zabol University of Medical Sciences (2012-2015) and Ardabil University of Medical Sciences (2016-2018) 🎓📖. His leadership roles include serving as Vice President of Education & Research at Khalkhal University (2019-2021) 📊🏛, where he contributed to advancing academic programs. Additionally, he was Student Manager (2018-2019) 🎓📋 and Head of the Scientometric Department (2018) 🔍📈. Dr. Mehraeen has been an active Research & Educational Council Member across various universities in Iran 📊🔬📚, fostering scientific collaboration and innovation. His extensive experience in medical education, research leadership, and scientometrics highlights his commitment to academic excellence and the advancement of healthcare sciences 📖🔬🏥.

Awards & Honors

Dr. Esmaeil Mehraeen is a distinguished researcher recognized as the Top Researcher in Ardabil Province (2021) 🏆🎖 for his outstanding contributions. His academic excellence began early, securing 1st place in the Ph.D. Entrance Exam (2015) 🥇📚 and being honored as an Exemplary Student in his MSc Program (2011) 🎓🏅. His dedication to research and education is evident through his active role as a member of Research & Educational Councils (2010-2021) 🏛📖, shaping academic policies and fostering innovation. Additionally, he played a key role in student research, serving as a member of the Student Research Committee at Iran University of Medical Sciences (2010-2011) 🔬👨‍🔬📚, contributing significantly to medical advancements. His commitment to academic excellence and research leadership continues to inspire students and scholars alike. 🌟📖

Research Focus

Dr. Esmaeil Mehraeen is a dedicated expert in health information management, medical informatics, and digital health solutions. 🏥💻 His research spans AI-driven chatbots in healthcare 🤖🏥, telemedicine innovations 📡📞, and self-management systems for HIV patients 🏥📲. He has contributed significantly to epidemiological studies on COVID-19 🦠📊, providing valuable insights into public health responses. His work also delves into ethical considerations in AI healthcare applications ⚖️🤖, health system security 🔐, and data-driven decision-making in public health 📊🌍. Through systematic reviews and meta-analyses 📚🔍, Dr. Mehraeen influences global health informatics research, shaping policies and advancing medical technologies. His interdisciplinary approach fosters innovation, improving healthcare accessibility and efficiency worldwide. 🌍💡👨‍🔬

Publication Top Notes

Predictors of mortality in patients with COVID-19–a systematic review

Late complications of COVID-19; a systematic review of current evidence

Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID‑19): a review of current evidence

The relationship between COVID‐19 viral load and disease severity: A systematic review

The challenges of E‑learning system: Higher educational institutions perspective

Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review

Effects of COVID-19 prevention procedures on other common infections: a systematic review

Post-synthetic functionalization of the metal-organic framework: Clean synthesis, pollutant removal, and antibacterial activity

 

Russka Shumnalieva | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Russka Shumnalieva | Medicine and Health Sciences | Best Researcher Award

Assist Prof Dr Russka Shumnalieva, Medical University-Sofia, Bulgaria, Bulgaria

Based on the details provided, Assist. Prof. Dr. Russka Shumnalieva appears to be a strong candidate for a Best Researcher Award.

Publication profile 

Orcid

  1. Expertise in Rheumatology: Dr. Shumnalieva has extensive experience in rheumatology, working at the largest university clinic for rheumatic diseases in Bulgaria. Her PhD thesis focuses on epigenetic modifications and their relation to rheumatic diseases, demonstrating in-depth research in disease mechanisms.
  2. Clinical Integration: Her research not only addresses theoretical aspects but also their application in clinical practice. Her work includes utilizing advanced techniques such as MSUS, capillaroscopy, and mini-invasive arthroscopy, showcasing her hands-on expertise in treating and monitoring patients.
  3. Translational Medicine Experience: Her fellowship at GBRC (Glasgow) and AMC (Amsterdam) provided her valuable experience in translational medicine, bridging the gap between laboratory research and clinical application.
  4. COVID-19 Research Contributions: Dr. Shumnalieva has co-authored significant research papers in top-tier journals, contributing to global studies on COVID-19 and its impact on autoimmune diseases, which underscores her relevance in current medical challenges.
  5. Multidisciplinary Collaborations: Her publications involve multidisciplinary, international collaborations on critical topics such as coronary artery diseases in vasculitides, multimorbidity in inflammatory myopathies, and lung involvement in systemic sclerosis.
  6. Public Health and Patient Care: With a Master’s in Public Health, Dr. Shumnalieva also explores the correlation between risk factors and rheumatic diseases, adding a valuable population health perspective to her research.
  7. Publication Record: With a solid portfolio of peer-reviewed articles in highly respected journals like Rheumatology International and International Journal of Rheumatic Diseases, Dr. Shumnalieva’s research addresses critical issues like the effect of multimorbidity on quality of life and disease flares post-COVID-19 infection.

    Publication top notes

    Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study

    Management of Coronary Artery Diseases in Systemic Vasculitides: Complications and Strategies

    The impact of multimorbidity on QoL in inflammatory myopathies: COVAD cluster analysis

    Lung Involvement in Systemic Sclerosis—From Pathogenesis to Prediction

    Exploring the Role of the Microbiome in Rheumatoid Arthritis—A Critical Review

    In the Pursuit of Precision: Novel Target Therapies Revolutionizing SLE Care

    Conclusion

    Dr. Shumnalieva’s extensive research background, innovative approaches to rheumatology, and contributions to understanding the intersection of autoimmune diseases and COVID-19 make her a standout candidate for the Best Researcher Award.